In Silico Tools to Extract the Drug Design Information Content of Degradation Data: The Case of PROTACs Targeting the Androgen Receptor

Proteolysis-Targeting Chimeras (PROTACs) have recently emerged as a promising technology in the drug discovery landscape. Large interest in the degradation of the androgen receptor (AR) as a new anti-prostatic cancer strategy has resulted in several papers focusing on PROTACs against AR. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Apprato, Giulia, D’Agostini, Giulia, Rossetti, Paolo, Ermondi, Giuseppe, Caron, Giulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919651/
https://www.ncbi.nlm.nih.gov/pubmed/36770875
http://dx.doi.org/10.3390/molecules28031206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919651/
https://www.ncbi.nlm.nih.gov/pubmed/36770875
http://dx.doi.org/10.3390/molecules28031206

Ejemplares similares